Cover Image
市場調查報告書

冠狀動脈硬化症:全球臨床實驗檢討

Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 310945
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈硬化症:全球臨床實驗檢討 Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2017
出版日期: 2017年07月19日 內容資訊: 英文 67 Pages
簡介

本報告提供冠狀動脈硬化症相關臨床研究之最新趨勢相關分析,為您彙整疾病·治療方法概要,及G7各國與E7(新興7國)的臨床實驗狀況,地區、Phase、階段別進行狀況,有潛力的贊助商,再加上各企業及研究機關的研究進行狀況,及有潛力的藥劑比較等資訊。

簡介

  • 冠狀動脈硬化症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 冠狀動脈硬化症臨床實驗數量中,心臟血管臨床實驗數量所佔的比例

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 冠狀動脈硬化症臨床實驗數量中,心臟血管臨床實驗數量所佔的比例

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗冠狀動脈硬化症

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 冠狀動脈硬化症治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • Cytori Therapeutics, Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • AstraZeneca PLC
    • MDDX LLC
    • Innovaderm Research Inc.
    • CardioVascular BioTherapeutics, Inc.
    • Avant Immunotherapeutics, Inc
  • 有代表性的研究機關醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • Providence VA Medical Center
    • National Taiwan University Hospital
    • Seoul National University Hospital
    • Rigshospitalet
    • University of Ottawa Heart Institute
    • University of California, San Diego
    • University of Minnesota
    • Massachusetts General Hospital
    • U.S. Department of Veterans Affairs

5大臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4338CTIDB

GlobalData's clinical trial report, "Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2017" provides an overview of Coronary Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Arteriosclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Coronary Arteriosclerosis Therapeutics Clinical Trials 31
  • Prominent Drugs 33
  • Clinical Trial Profile Snapshots 34

Appendix 65

  • Abbreviations 65
  • Definitions 65
  • Research Methodology 66
  • Secondary Research 66
  • About GlobalData 67
  • Contact Us 67
  • Source 67

List of Tables

List of Tables

  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 16
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 20
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2017* 23
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
  • Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures

List of Figures

  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 24
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
  • Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
  • GlobalData Methodology 66
Back to Top